1
Clinical Trials associated with HS234HS234片治疗ER+/Her2-晚期乳腺癌患者的安全性、耐受性及药代动力学Ⅰ期临床试验
[Translation] Phase I clinical trial on the safety, tolerability and pharmacokinetics of HS234 tablets in the treatment of ER+/Her2- advanced breast cancer patients
主要目的:评估HS234片在ER+/Her2-晚期乳腺癌患者中的安全性和耐受性,评价HS234片在晚期乳腺癌患者中单次和多次口服给药的药代动力学特征;
次要目的:探索HS234片的Ⅱ期推荐剂量,探索HS234片在转移性或局部晚期乳腺癌患者中的初步疗效。
[Translation] Primary purpose: To evaluate the safety and tolerability of HS234 tablets in patients with ER+/Her2- advanced breast cancer, and to evaluate the pharmacokinetic characteristics of HS234 tablets after single and multiple oral administration in patients with advanced breast cancer;
Secondary purpose: To explore the recommended Phase II dose of HS234 tablets, and to explore the preliminary efficacy of HS234 tablets in patients with metastatic or locally advanced breast cancer.
100 Clinical Results associated with HS234
100 Translational Medicine associated with HS234
100 Patents (Medical) associated with HS234
100 Deals associated with HS234